Kannaway ™ Gold Premium Hemp Oil

Please, select Your language version:

American VersionDeutsch VersionÖsterreichische VersionVersione ItalianaVersion FrançaiseČeská Verze
Kannaway ™ Gold Premium Hemp Oil

Kannaway ™ Gold Premium Hemp Oil

Kannaway ™ Gold Premium Hemp Oil is a full-spectrum, filtered CBD hemp oil, extracted from the hemp plant and packaged pure with no other ingredients or additives. If you’re looking for a high concentration of CBD, Kannaway ™ Gold is for you. Kannaway ™ Gold contains more CBD per serving than any other product we offer. Each 15 gram tube contains 30 servings for a month’s worth of daily CBD hemp oil supplements. Kannaway ™ Gold Premium Hemp Oil is our highest potency product in the store, providing 120 mg of CBD per serving and 3600 mg of CBD per tube. Kannaway ™ Gold Premium Hemp Oil is decarboxylated to maximize CBD content and put through an additional filtration process to remove the hemp oil’s excess waxes, chlorophyll, and plant material, giving the oil its golden color and refined taste.


Turn dial on oral applicator approximately one half turn to dispense 0.5 grams of oil. Dispense oil onto finger or butter knife or place under the tongue. Hold in mouth 60-90 seconds before swallowing. Larger or smaller servings may be taken as desired.


Pure CBD Hemp Oil.

See also:


  1. Cary Leizer BA, David Ribnicky PhD, Alexander Poulev PhD, Slavik Dushenkov PhD & Ilya Raskin PhD (2015) The Composition of Hemp Seed Oil and Its Potential as an Important Source of Nutrition, Journal of Nutraceuticals, Functional & Medical Foods, 2:4, 35-53
  2. Montserrat-De La Paz, S., et al. “Hemp (Cannabis sativa L.) seed oil: analytical and phytochemical characterization of the unsaponifiable fraction.” Journal of agricultural and food chemistry 62.5 (2014): 1105-1110.
  3. Malingre, Th, et al. “The essential oil of Cannabis sativa.” Planta medica 28.05 (1975): 56-61.
  4. Palmieri, Beniamino, Carmen Laurino, and Maria Vadalà. “Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome after Human Papillomavirus Vaccination.” The Israel Medical Association journal: IMAJ 19.2 (2017): 79-84.

Please, Share this article on: